In The News Posted November 13, 2021 Share Posted November 13, 2021 WESTPORT, Conn., Nov. 13, 2021 /PRNewswire/ -- Intensity Therapeutics, Inc. ("Intensity"), a clinical-stage biotechnology company focused on the discovery and development of proprietary immune-based intratumoral cancer therapies designed to kill tumors and increase immune system...View the full article Quote Link to comment Share on other sites More sharing options...
Recommended Posts